Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Urologix names Spangler to the board

August 19, 2010 3:45 pm | by The Associated Press | News | Comments

Medical device company Urologix Inc. said Thursday it named Patrick D. Spangler to its board of directors.Spangler's experience includes over 23 years in the medical field. He has worked in management roles with ev3, Empi Inc. and Medtronic Inc.

Beijing Goodwill and IBM Team to Improve Detection of Cardiovascular Diseases

August 19, 2010 1:34 pm | by IBM | News | Comments

Beijing Goodwill Information and Technology Co., Ltd., a leading provider of electronic cardiogram systems in China, and IBM announced the launch of the country's first all-in-one electronic cardiogram management system in China. This system supports smarter healthcare by helping...

TOPICS:

PLC Medical Systems Implements Omnify Software as Core of Quality Management System

August 19, 2010 11:45 am | by PLC Medical Systems | Articles | Comments

Challenge: Homegrown Access database to manage product data PLC Medical Systems Inc. a medical technology company specializing in innovative technologies for the cardiac and vascular markets, was managing product data with a homegrown Access database system. Requiring a great deal of manual intervention and paper processes, something as small as a change in a Quality document required the document to be printed out, old documents pulled from a folder and put in the new version, and then brought from person to person (engineering, quality control, operations) for sign-off. This setup did not have the proper tracking for who was actually trained on a certain procedure, or who signed off on an Engineering Change Order (ECO) and when. In addition, it did not allow PLC to capture employee product knowledge should someone leave.

Advertisement

Fitch Ratings upgrades McKesson ratings

August 19, 2010 11:45 am | by The Associated Press | News | Comments

Fitch Ratings on Thursday upgraded several of McKesson Corp.'s ratings and gave the drug distributor a stable outlook, citing better leverage and growth.Fitch upgraded the issuer default rating, senior unsecured credit, and senior unsecured debt to 'A-' from 'BBB+', or to upper medium grade...

Fitch Ratings upgrades Cardinal Health ratings

August 19, 2010 11:45 am | by The Associated Press | News | Comments

Fitch Ratings upgraded Cardinal Health and gave a positive outlook Thursday, citing the health care products distributor's leverage.Fitch upgraded the issuer default rating, unsecured bank debt, and senior unsecured debt to 'BBB+' from 'BBB', both of which are the same lower medium grade...

PatientsLikeMe take in $8M funding

August 19, 2010 11:35 am | by Mass High Tech: The Journal of New England Technology | News | Comments

PatientsLikeMe Inc., a Cambridge-based social networking site focused on health care, has raised $8 million of a planned $30 million equity financing. The company runs an online community for people with various life-changing diseases.

BioStorage Technologies to Sponsor and Present Educational Workshops at Annual Biorepositories Conference

August 19, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, Aug. 19 /-  BioStorage Technologies Inc., a global leader in sample management, cold chain logistics and biomaterial storage for the pharmaceutical and biotechnology industries, will be a lead sponsor and presenter at the 3rd annual Biorepositories Conference, September...

TOPICS:

U.S. Appeals Court Reinstates Claim That Controversial Diet Drug Redux Should Never Have Been Offered to American People

August 19, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Ohio, Aug. 19 /PRNewswire-USNewswire/ -- An Ohio Federal Court of Appeals ruling issued yesterday is reinstating the late victim's claim that the recalled diet drug Redux (commonly called fen-phen) linked to her death should never have been marketed to the American people by...

TOPICS:
Advertisement

Perrigo Confirms Filing for Clobetasol Shampoo and Announcement of Patent Infringement Lawsuit by Galderma

August 19, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

ALLEGAN, Mich., Aug. 19 /- Perrigo Company (Nasdaq: PRGO;TASE) announced its filing with the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for clobetasol propionate shampoo, 0.05%, and notified Galderma, the listed patent owner. On August 17,...

TOPICS:

Supplemental Oxygen Company Offers Steps to Improve COPD Patients' Lives

August 19, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Aug. 19 /- What is the fourth leading cause of death in the United States? Many would be surprised to learn that chronic obstructive pulmonary disease (COPD) is, and the number of people with COPD is increasing. According to the COPD Foundation, more than 12 million...

TOPICS:

DrChrono.com iPad EMR Unveils Electronic Prescription Feature

August 19, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 19 /- DrChrono.com , the premier publisher of dynamic point-of-care and practice management software, today announced the latest version of its signature iPad EMR platform , which offers electronic prescribing (eRx). "Studies have shown that eRx cuts down errors resulting...

TOPICS:

MicroAire Surgical Instruments Acquires Endotine® (Formerly Owned by Coapt Systems)

August 19, 2010 11:32 am | by Bio-Medicine.Org | News | Comments

CHARLOTTESVILLE, Va., Aug. 19 /- MicroAire Surgical Instruments is pleased to announce the acquisition of Endotine® bioabsorbable, multi-point, soft-tissue fixation systems for facial aesthetic surgery. Endotine® is a patented system that allows surgeons to attach soft tissue to...

TOPICS:

New Pavilion Adds Complete Finishing Component to FABTECH 2010 in Atlanta

August 19, 2010 9:32 am | by Society of Manufacturing Engineers | News | Comments

DEARBORN, Mich., August 18, 2010 - A new Finishing Technologies Pavilion & Conference debuting at FABTECH 2010 Nov. 2-4 in Atlanta allows manufacturing executives to review finishing equipment, processes and services, and gain valuable technical insight. Sponsored by the Chemical...

Acceleron DMD drug gets orphan drug status

August 19, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Acceleron Pharma Inc. has won financial incentives and enhanced protection from generic competition, for its drug candidate to treat Duchenne Muscular Dystrophy, a fatal neuromuscular disease.

Achillion Pharma aims for $50M in stock sale

August 19, 2010 9:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Antiviral drug developer Achillion Pharmaceuticals Inc. said today that it plans to raise $50 million by selling stock to four venture capital firms.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading